1 completed, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow sparsentan: new trials by email Literature Review of sparsentan trials Research Report on sparsentan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria sparsentan, No sparsentan - Proteinuric Renal Disease, Proteinuric Kidney Disease | Phase 1 | Recruiting | Brigham and Women's Hospital | 20 | 2026-07-10 | 2026-07-30 |
| Study to Evaluate the Pharmacokinetics of Oral Sparsentan Suspension RE-021, sparsentan - Healthy Subjects | Phase 1 | Completed | Travere Therapeutics, Inc. | 47 | 2020-06-18 | 2022-09-30 |
Glomerulonephritis, IGA (1) · Glomerulosclerosis, Focal Segmental (1) · Neoplasms (1) · Proteinuria (1)
Brigham and Women's Hospital (1) · Travere Therapeutics, Inc. (1)
United Kingdom (1) · United States (1)